Molecular diagnostics is a rapidly evolving field with frequently changing standards for care that challenge the current paradigm for coding, coverage and payment. In 2019, the Association for Molecular Pathology (AMP) brought together stakeholders from across the molecular diagnostics spectrum for a one-day summit aimed at improving the molecular diagnostics economic landscape. Following the success of this event, it was our intention to gather annually to discuss our rapidly evolving field and address how the current paradigm for coding, coverage, and payment must evolve to meet the changing standards of medical care.
The COVID-19 pandemic and its call to action for molecular professionals around the globe made this impossible in 2020 and 2021. We are increasingly confident that 2022 will provide us with an opportunity to gather safely and continue the work we started with the first AMP Molecular Pathology Economics Summit.
We aim to harness the collective expertise of our community to advance the national dialogue toward improving patient access to appropriate molecular diagnostic care. Attendees will participate in guided discussions to identify barriers to appropriate reimbursement for molecular pathology procedures and then have the opportunity to propose solutions to critical challenges that are limiting full realization of the possibilities offered by precision medicine. The Summit will connect experts across multiple industries and professional arenas harnessing the collective effort to advance the national dialogue towards improving patient access to appropriate molecular diagnostic care.
AMP’s Molecular Pathology Economics Summit will be a highly interactive one-day gathering focused on:
Note Regarding the Ongoing COVID-19 Pandemic:
The safety of our participants is our number one concern. This event is currently being planned as an in-person event. This event will comply with all current DC COVID-19 regulations, and we will keep registrants updated with the full requirements.
Samuel K. Caughron, MD
Chair, AMP Economic Affairs Committee
MAWD Pathology Group, P.A.
While each stakeholder is impacted by unique issues, there is common alignment around an interest in improving the overall economics for diagnostic testing. Advances in diagnostic testing and closely related therapies are driving precision medicine, while at the same time continuing to challenge current paradigms for molecular diagnostic coding, coverage and reimbursement.
During the morning sessions, a series of roundtable discussions will be held, each focused on a specific economic challenge plaguing molecular diagnostic testing. We invite participants from all stakeholder perspectives including clinical laboratories, pharmaceutical companies, in vitro diagnostic manufacturers, and patient advocacy groups to participate in these interactive candid discussions, with the ultimate goal of mutual understanding and identification of common areas in which to assign resources to improve the economics of molecular testing in in the interest of patient access.
In the afternoon, attendees will participate in an interactive session that aims to identify actionable ideas to address the coding, coverage, and reimbursement issues for molecular diagnostic tests and develop avenues for the diverse stakeholder groups to unite and push these ideas to completion. More information on the afternoon session structure and instructions for those interested in sharing their ideas can be found in the preliminary agenda below.
|8:00am||Welcome and Opening Remarks|
|8:15am||Real World Perspectives: How the pandemic affected molecular diagnostic testing, the laboratories that
perform these tests, and patient access
|9:00am||Real World Perspectives: How CODING is a barrier for patient access|
|10:15am||Real World Perspectives: How PRICING is a barrier for patient access|
|11:00am||Real World Perspectives: How COVERAGE is a barrier for patient access|
|12:15pm||Lunch-time Presentation: AMP EAC Coding, Coverage, and Reimbursement Strategies|
|12:30pm||Introduction to Afernoon Sessions|
Innovation Lab - Part 1
In the first Innovation Lab session, five selected participants will be given the floor to present and build support for their novel solutions that are designed to target and address overarching pain points identified by this community related to coding, coverage, and reimbursement of molecular diagnostic testing. This session provides a forum for ideas to be shared – with the goal of garnering broad perspectives on such an approach, as well as offer an opportunity to potentially garner support and resources to help accelerate these solutions. The audience will vote on the most promising idea.
SUBMIT AN APPLICATION TO PRESENT IN THIS SESSION (Applications Open May 16th): ALL participants with suggestions or proposals to improve patient access through either the coding, coverage, or reimbursement system for molecular diagnostics are invited to apply. Participants are welcome to present projects that their organization is already actively working on or to present a novel idea.
|2:00pm||Coffee Break and Vote Counting|
Innovation Lab - Part 2
Participants will develop a cross-industry plan to support and push the winning idea forward within their respective stakeholder group over the next few years.
AMP Economic Affairs Committee Vice Chair: Coverage Decisions
Pranil Chandra, DO
AMP Economic Affairs Committee Vice Chair: New Codes and Pricing
Jay Patel, MD
AMP Economic Affairs Committee Past-Vice Chair: New Codes and Pricing
Anthony Sireci, MD, MSc
AMP Economic Affairs Committee Junior Member
Nicholas Bevins, MD, PhD
AMP Economic Affairs Committee Member
Tanner Hagelstrom, PhD, MBA
AMP Economic Affairs Committee Member
Victoria Pratt, PhD
AMP Economic Affairs Committee Member
Salvatore Priore, MD, PhD
University of Pennsylvania
Registration pricing is for a single individual. Please select your registration type based on your current organization. To register for this event 1.) click Register (above) 2.) either login using your AMP credentials or scroll down to create a new account.
IMPORTANT: Participation is limited and we encourage you to register and reserve your space as soon as possible. We anticipate that this event will sell-out.
|Registration Type|| Advanced Registration
(Until June 13th)
(June 14th Onward)
|Associations & Patient Advocacy Groups*||First Attendee from your organization is FREE||First Attendee from your organization is FREE|
|Non-Profit Organizations||$375 USD||$400 USD|
|For-Profit Organizations**||$950 USD||$1,150 USD|
*Association and Patient Advocacy Groups - The first attendee from any association or patient advocacy group will receive free registration. Additional registrants from any association or patient advocacy group must register at the Non-Profit registration rate. To access your free registration (or to confirm if you are the first registrant), please contact the AMP Public Policy and Advocacy Department at: email@example.com
**Corporate Advisory Council members may receive free registration as a benefit of AMP Partnership. Please contact Laurie Menser (firstname.lastname@example.org) regarding these registrations.
Cancellation Policy: Cancellations received by written notification to email@example.com through JUly 1st will receive a refund (less a $100 processing fee). No refunds after July 1st.
Pay by Check: To pay by check please contact us at firstname.lastname@example.org.
1.) Click the Register Now button above
2.) Login using your AMP credentials or conduct a password reset
3.) Don't have a AMP credentials? Click "New User? Click Here" to create an account
4.) Once logged in, click "Events" at the top of the page
5.) Select the Molecular Pathology Economics Summit and proceed.
If you have any questions during the registration proces contact us at email@example.com.
The 2022 AMP Molecular Pathology Economics Summit will be held at the Conrad Washington D.C. Hotel. AMP has negotiated with the host venue to provide attendees with the discounted room rate of $299.00 (USD) per night (+applicable taxes and fees). The Hotel Reservation Deadline is June 23, 2022.
Generously Supported By
SPONSOR THIS EVENT
For more information on becoming an Industry Partner for this event please contact, Laurie Menser.